The Covid-19 pandemic’s rapid spread across the world demanded a quick, collaborative response. Now, experts are asking how they can take the lessons from combating Covid-19 and apply them to diseases like cancer.
“As we look at Covid and the lessons we’re learning in the last year-and-a-half, it certainly is a lesson of successes and failures,” said John Oyler, CEO of BeiGene, in an event at the Milken Institute Future of Health Summit this week. “I strongly believe in oncology that we can and will learn from this set of experiences.”
The oncology community has already had to learn some of those lessons on the fly, as Covid-19 restrictions forced more patient care and clinical trials to be conducted remotely. Many researchers didn’t have the background or technology needed to carry out virtual assessments.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
